期刊文献+

S-adenosyl-L-methionine modifies antioxidant-enzymes,glutathione-biosynthesis and methionine adenosyltransferases-1/2 in hepatitis C virus-expressing cells 被引量:2

下载PDF
导出
摘要 AIM: To elucidate the mechanism(s) by which S-adenosyl-L-methionine(SAM) decreases hepatitis C virus(HCV) expression.METHODS: We examined the effects of SAM on viral expression using an HCV subgenomic replicon cell culture system. Huh7 HCV-replicon cells were treated with 1 mmol/L SAM for different times(24-72 h), then total RNA and proteins were isolated. c DNA was synthesized and real time-PCR was achieved to quantify HCV-RNA, superoxide dismutase 1 and 2(SOD-1, SOD-2) catalase, thioredoxin 1, methionine adenosyltransferase 1A and 2A(MAT1A, MAT2A) expression, and GAPDH and RPS18 as endogenous genes. Expression of cellular and viral protein was evaluated by western-blot analysis using antibodies vs HCV-NS5 A, SOD-1, SOD-2, catalase, thioredoxin-1, MAT1 A, MAT2 A, GAPDH and actin. Total glutathione levels were measured at different times by Ellman's recycling method(0-24 h). Reactive oxidative species(ROS) levels were quantified by the dichlorofluorescein assay(0-48 h); Pyrrolidin dithiocarbamate(PDTC) was tested as an antioxidant control and H2O2 as a positive oxidant agent.RESULTS: SAM exposition decreased HCV-RNA levels 50%-70% compared to non-treated controls(24-72 h). SAM induced a synergic antiviral effect with standard IFN treatment but it was independent of IFN signaling. In addition, 1 mmol/L SAM exposition did not modify viral RNA stability, but it needs cellular translation machinery in order to decrease HCV expression. Total glutathione levels increased upon SAM treatment in HCV-replicon cells. Transcriptional antioxidant enzyme expression(SOD-1, SOD-2 and thioredoxin-1) was increased at different times but interestingly, there was no significant change in ROS levels upon SAM treatment, contrary to what was detected with PDTC treatment, where an average 40% reduction was observed in exposed cells. There was a turnover from MAT1A/MAT2 A, since MAT1 A expression was increased(2.5 fold-times at 48 h) and MAT2 A was diminished(from 24 h) upon SAM treatment at both the transcriptional and translational level. CONCLUSION: A likely mechanism(s) by which SAM diminish HCV expression could involve modulating antioxidant enzymes, restoring biosynthesis of glutathione and switching MAT1/MAT2 turnover in HCV expressing cells. AIM: To elucidate the mechanism(s) by which S-adenosyl-L-methionine (SAM) decreases hepatitis C virus (HCV) expression.METHODS: We examined the effects of SAM on viral expression using an HCV subgenomic replicon cell culture system. Huh7 HCV-replicon cells were treated with 1 mmol/L SAM for different times (24-72 h), then total RNA and proteins were isolated. cDNA was synthesized and real time-PCR was achieved to quantify HCV-RNA, superoxide dismutase 1 and 2 (SOD-1, SOD-2) catalase, thioredoxin 1, methionine adenosyltransferase 1A and 2A (MAT1A, MAT2A) expression, and GAPDH and RPS18 as endogenous genes. Expression of cellular and viral protein was evaluated by western-blot analysis using antibodies vs HCV-NS5A, SOD-1, SOD-2, catalase, thioredoxin-1, MAT1A, MAT2A, GAPDH and actin. Total glutathione levels were measured at different times by Ellman&#x02019;s recycling method (0-24 h). Reactive oxidative species (ROS) levels were quantified by the dichlorofluorescein assay (0-48 h); Pyrrolidin dithiocarbamate (PDTC) was tested as an antioxidant control and H<sub>2</sub>O<sub>2</sub> as a positive oxidant agent.RESULTS: SAM exposition decreased HCV-RNA levels 50%-70% compared to non-treated controls (24-72 h). SAM induced a synergic antiviral effect with standard IFN treatment but it was independent of IFN signaling. In addition, 1 mmol/L SAM exposition did not modify viral RNA stability, but it needs cellular translation machinery in order to decrease HCV expression. Total glutathione levels increased upon SAM treatment in HCV-replicon cells. Transcriptional antioxidant enzyme expression (SOD-1, SOD-2 and thioredoxin-1) was increased at different times but interestingly, there was no significant change in ROS levels upon SAM treatment, contrary to what was detected with PDTC treatment, where an average 40% reduction was observed in exposed cells. There was a turnover from MAT1A/MAT2A, since MAT1A expression was increased (2.5 fold-times at 48 h) and MAT2A was diminished (from 24 h) upon SAM treatment at both the transcriptional and translational level.CONCLUSION: A likely mechanism(s) by which SAM diminish HCV expression could involve modulating antioxidant enzymes, restoring biosynthesis of glutathione and switching MAT1/MAT2 turnover in HCV expressing cells.
出处 《World Journal of Gastroenterology》 SCIE CAS 2016年第14期3746-3757,共12页 世界胃肠病学杂志(英文版)
基金 Supported by CONACYT-Mexico,grant register CB2010-01-155082 to Rivas-Estilla AM
  • 相关文献

参考文献32

  • 1Danielle Venturini,Andréa Name Colado Sim?o,Décio Sabbatini Barbosa,Edson Lopes Lavado,Victor Emanuel Soares Narciso,Isaias Dichi,Jane Bandeira Dichi.??Increased Oxidative Stress, Decreased Total Antioxidant Capacity, and Iron Overload in Untreated Patients with Chronic Hepatitis C(J)Digestive Diseases and Sciences . 2010 (4)
  • 2Patrizia Burra.??Hepatitis C(J)Semin Liver Dis . 2009 (01)
  • 3Quentin M. Anstee,Christopher P. Day.??S -adenosylmethionine (SAMe) therapy in liver disease: A review of current evidence and clinical utility(J)Journal of Hepatology . 2012 (5)
  • 4Richard J.O. Barnard,John A. Howe,Robert A. Ogert,Stefan Zeuzem,Fred Poordad,Stuart C. Gordon,Robert Ralston,Xiao Tong,Vilma Sniukiene,Julie Strizki,Desmond Ryan,Jianmin Long,Ping Qiu,Clifford A. Brass,Janice Albrecht,Margaret Burroughs,Scott Vuocolo,Daria J. Hazuda.??Analysis of boceprevir resistance associated amino acid variants (RAVs) in two phase 3 boceprevir clinical studies(J)Virology . 2013 (1-2)
  • 5James Mike Brown,Christopher Kuhlman,Marcus V. Terneus,Matthew T. Labenski,Andre Benja Lamyaithong,John G. Ball,Serrine S. Lau,Monica A. Valentovic.??S-adenosyl- l -methionine protection of acetaminophen mediated oxidative stress and identification of hepatic 4-hydroxynonenal protein adducts by mass spectrometry(J)Toxicology and Applied Pharmacology . 2014
  • 6Liyun Yuan,Neil Kaplowitz.??Glutathione in liver diseases and hepatotoxicity(J)Molecular Aspects of Medicine . 2008 (1)
  • 7Michael P Manns,John G McHutchison,Stuart C Gordon,Vinod K Rustgi,Mitchell Shiffman,Robert Reindollar,Zachary D Goodman,Kenneth Koury,Mei-Hsiu Ling,Janice K Albrecht.??Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial(J)The Lancet . 2001 (9286)
  • 8Shelly C Lu.??S -Adenosylmethionine(J)International Journal of Biochemistry and Cell Biology . 2000 (4)
  • 9Matías A Avila,Carmen Berasain,Luis Torres,Antonio Martín-Duce,Fernando J Corrales,Heping Yang,Jesús Prieto,Shelly C Lu,Juan Caballería,Juan Rodés,José M Mato.??Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma(J)Journal of Hepatology . 2000 (6)
  • 10Mato JM,Lu SC.RoleofS-adenosyl-L-methionineinliverhealthandinjury. Hepatology . 2007

共引文献4

同被引文献9

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部